Elisa Avolio
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Single-cell transcriptomic analysis of the human vascular atlas provides new insights into vasorelaxation redundancy and heterogeneity.
Journal: Frontiers in cardiovascular medicine
Published: May 24, 2025
Functional Characterization of the Hephaestin Variant D568H Provides Novel Mechanistic Insights on Iron-Dependent Asbestos-Induced Carcinogenesis.
Journal: International journal of molecular sciences
Published: February 05, 2025
Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?
Journal: Pharmacological reviews
Published: December 04, 2024
MEK inhibitors: a promising targeted therapy for cardiovascular disease.
Journal: Frontiers in cardiovascular medicine
Published: March 20, 2024
The role of cardiac pericytes in health and disease: therapeutic targets for myocardial infarction.
Journal: Nature reviews. Cardiology
Published: July 10, 2023
The tyrosine kinase inhibitor Dasatinib reduces cardiac steatosis and fibrosis in obese, type 2 diabetic mice.
Journal: Cardiovascular diabetology
Published: June 05, 2023
BPIFB4 and its longevity-associated haplotype protect from cardiac ischemia in humans and mice.
Journal: Cell death & disease
Published: January 22, 2023
Murine studies and expressional analyses of human cardiac pericytes reveal novel trajectories of SARS-CoV-2 Spike protein-induced microvascular damage.
Journal: Signal transduction and targeted therapy
Published: January 11, 2023
The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy.
Journal: Cardiovascular research
Published: October 24, 2022
The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease.
Journal: Clinical science (London, England : 1979)
Published: July 16, 2021
Cardiac pericyte reprogramming by MEK inhibition promotes arteriologenesis and angiogenesis of the ischemic heart.
Journal: The Journal of clinical investigation
Published: June 14, 2021
Last Updated: 09/26/2026